HK Stock MarketDetailed Quotes

00911 QIANHAI HEALTH

Watchlist
  • 0.335
  • +0.015+4.69%
Market Closed Nov 8 16:08 CST
56.76MMarket Cap0.76P/E (TTM)

About QIANHAI HEALTH Company

Qianhai Health Holdings Limited (formerly known as Hengfa Ginseng Holdings Limited) was incorporated as an exempted limited company in the Cayman Islands under Chapter 22 of the Cayman Islands Companies Act (Act No. 33 of 1961, consolidated and amended) on 2011/8/18, and was officially listed on the main board of the Hong Kong Stock Exchange on 2014/6/27. The stock code is 0911. The core business of Qianhai Health Holdings Limited (the “Company”) and its subsidiaries (collectively “Qianhai Health” or the “Group”) is the procurement and wholesale of American ginseng (PanaxquinqueFoliusL). , a perennial herb of the family Cinaceae, including cultivated ginseng and wild ginseng). The company was founded 30 years ago, has always been supported by customers, and has accumulated quite a lot of experience in the industry. Drawing on its valuable experience in the past, the Group began as early as the early 90s, regularly appointing senior specialists to the US and Canada to purchase supplies, adhering to a strict attitude of selecting materials. Coupled with rich knowledge and experience, the Group's business development has steadily increased, and it has become the largest supplier of ginseng in the industry. Hong Kong, China, is regarded as the world's most important shipping port for Western ginseng. About 90% of Canadian ginseng is exported to Hong Kong, China, and the Group is the largest first-class Western ginseng wholesaler in Hong Kong, China. As a leading company in the market, the Group has strong bargaining power with customers, growers and suppliers. In 2017, the Group established Zhejiang Huizun Investment Management Co., Ltd., a wholly-owned subsidiary in China.” “Zhejiang Huizun” is currently jointly developing the Lin'an Tuankou Hot Spring Villa, as well as a medical and physical examination center, with a total construction area of 70,000 square meters. The Group's long-term development vision is through the construction, mergers and acquisitions and management of general hospitals. General hospitals seek to combine medical, rehabilitation, and health care specialties. Let the group establish a major industrial platform in Hangzhou, so that the concept of a big health industry model can be fully implemented, and strive to occupy an important position in the Hangzhou health and wellness medical industry.

Company Profile

Symbol00911
Company NameQIANHAI HEALTH
ISINKYG7307F1129
Listing DateJun 27, 2014
Issue Price1.98
Shares Offered500.00M share(s)
FoundedAug 18, 2011
Registered AddressCayman Islands
Chairmanzhiqun huang
Secretaryderong ye
Audit InstitutionEvergreen (Hong Kong) Certified Public Accountants Limited
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeCricket Square, Hutchins Drive P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of BusinessRoom 301-303, 3rd floor, Wing Tak Commercial Centre, 177-183 Wing Lok Street, Sheung Wan, Hong Kong
Fiscal Year Ends12-31
Employees16
MarketHong Kong motherboard
Phone(852) 2545 7083
Fax(852) 2815 4099
Emailir@qhhl.com.hk
Business Qianhai Health Holdings Co., Ltd. is an investment holding company mainly engaged in the procurement and wholesale of American ginseng products. The company and its subsidiaries operate through four major divisions. The Ginseng Cultivation Division is engaged in the procurement and sale of cultivated American ginseng. The Wild Ginseng Division is engaged in the procurement and sale of American wild ginseng. The Mountain Ginseng Liquor Division is engaged in the production and sale of Wild Ginseng Liquor. Its liquor products include Wild Ginseng Cognac Brandy Liquor and Wild Ginseng Liquor. Other divisions trade other products, including Cordyceps sinensis, dried bird's nest, seafood, and skin care products.

Company Executives

  • Name
  • Position
  • Salary
  • zhiqun huang
  • Chairman of the Board, Non-executive Directors, Authorized Representative
  • --
  • jie lin
  • Non-executive Directors
  • 195.00K
  • kaiben chen
  • Non-executive Directors
  • --
  • qi chen
  • Non-executive Directors
  • --
  • wei li
  • Independent Non-Executive Director, Remuneration Committee Chairman, Chairman of the Nomination Committee, Audit Committee Members
  • 180.00K
  • zhendong liang
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
  • 180.00K
  • yuyuan tang
  • Executive Director
  • --
  • zili yuan
  • Executive Director, Nomination Committee Members, Remuneration Committee Members
  • 180.00K
  • derong ye
  • Chief Financial Officer, Authorized Representative, Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data